Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

"> 回首頁LOGO按鈕

繁簡 EN

最新消息

News & Message

:::

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

最新消息

2026/2/3

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

側邊開關圖示

中國醫點通

百度搜狗 360搜索硬科技投向标|国资委：瞄准人工智能加快打造一批“杀手锏”技术 OpenAI官宣400亿美元最新融资抗战回望09︱抗战时期富人的义务：有钱出钱，有力出力！美国网红“甲亢哥”游香港直播总观看人次逾748万 4男子盗窃1.6元被刑拘警方回应叶童怼房琪

<code id='1efcf'></code><style id='5f729'></style>

<acronym id='12115'></acronym>

<center id='d8d1e'><center id='b5892'><tfoot id='b8b4c'></tfoot></center><abbr id='3c76c'><dir id='2752d'><tfoot id='26725'></tfoot><noframes id='71184'>

<optgroup id='65b79'><strike id='86d89'><sup id='8c6e2'></sup></strike><code id='eb712'></code></optgroup>

<b id='4dea7'><label id='483c7'><select id='fd03c'><dt id='30d64'><span id='267f1'></span></dt></select></label></b><u id='ae33e'></u>

~~<i id='6651c'><strike id='3d0b8'><tt id='ea2b6'><pre id='beade'></pre></tt></strike></i>~~